Aceragen is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. Our portfolio includes late-stage programs that we are developing to be innovative therapeutics capable of addressing the unmet medical needs of those individuals.
Jan 17, 2023
Nov 14, 2022
Sep 28, 2022
Data Provided by Refinitiv. Minimum 15 minutes delayed.